LDLeda Dimou

Leda Dimou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leda Dimou has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Michael Wegner

    Institut für Biochemie, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany

    4 shared publications
  • Magdalena Götz

    Institute for Stem Cell Research, Helmholtz Center Munich, Biomedical Center, Planegg-Martinsried, Germany

    3 shared publications
  • Christiane Simon

    Physiological Genomics, Institute of Physiology, Ludwig-Maximilians University, Munich, Germany

    2 shared publications
  • Frank Kirchhoff

    Molecular Physiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), University of Saarland, Homburg, 66421, Germany; Center for Gender-specific Biology and Medicine (CGBM), University of Saarland, Homburg, 66421, Germany; Pharmaceutical Research Center for Gender-specific Biology and Medicine, China Pharmaceutical University, 639 Longmian Dadao, Jiangning District, Nanjing, 210009, China

    2 shared publications
  • Sarah Schneider

    Physiological Genomics, Biomedical Center, Ludwig-Maximilians University, Munich, Germany

    2 shared publications
  • Agnès Gruart

    División de Neurosciencias, Universidad Pablo de Olavide, Seville, Spain

    1 shared publication

Latest Publications

  • NG2-glia, More Than Progenitor Cells

    by Jaime Eugenín-Von Bernhardi, Leda Dimou

    NG2-glia are a mysterious and ubiquitous glial population with a highly branched morphology. Initial studies suggested that their unique function is the generation and maintenance of oligodendrocytes in the central nervous system (CNS), important for proper myelination and therefore for axonal support and fast conduction velocity. Over the last years this simplistic notion has been dramatically changed: the wide and homogeneous distribution of NG2-glia within all areas of the developing CNS that is maintained during the whole lifespan, their potential to also differentiate into other cell types in a spatiotemporal manner, their active capability of maintaining their population and their dynamic behavior in altered conditions have raised the question: are NG2-glia simple progenitor cells or do they play further major roles in the normal function of the CNS? In this chapter, we will discuss some important features of NG2-glia like their homeostatic distribution in the CNS and their potential to differentiate into diverse cell types. Additionally, we will give some further insights into the properties that these cells have, like the ability to form synapses with neurons and their plastic behavior triggered by neuronal activity, suggesting that they may play a role specifically in myelin and more generally in brain plasticity. Finally, we will briefly review their behavior in disease models suggesting that their function is extended to repair the brain after insult.


  • Decrease in newly generated oligodendrocytes leads to motor dysfunctions and changed myelin structures that can be rescued by transplanted cells

    by Sarah Schneider, Agnès Gruart, Sofia Grade, Yina Zhang, Stephan Kröger, Frank Kirchhoff, Gregor Eichele, José M. Delgado García, Leda Dimou

    NG2-glia in the adult brain are known to proliferate and differentiate into mature and myelinating oligodendrocytes throughout lifetime. However, the role of these newly generated oligodendrocytes in the adult brain still remains little understood. Here we took advantage of the Sox10-iCreERT2 x CAG-eGFP x Esco2fl/fl mouse line in which we can specifically ablate proliferating NG2-glia in adult animals. Surprisingly, we observed that the generation of new oligodendrocytes in the adult brain was severely affected, although the number of NG2-glia remained stable due to the enhanced proliferation of non-recombined cells. This lack of oligodendrogenesis led to the elongation of the nodes of Ranvier as well as the associated paranodes, which could be locally rescued by myelinating oligodendrocytes differentiated from transplanted NG2-glia deriving from wildtype mice. Repetitive measurements of conduction velocity in the corpus callosum of awake animals revealed a progressive deceleration specifically in the mice lacking adult oligodendrogenesis that resulted in progressive motor deficits. In summary, here we demonstrated for the first time that axon function is not only controlled by the reliable organization of myelin, but also requires a dynamic and continuous generation of new oligodendrocytes in the adult brain. GLIA 2016;64:2201–2218


  • GPR17 expressing NG2‐Glia: Oligodendrocyte progenitors serving as a reserve pool after injury

    by Francesca Viganò, Sarah Schneider, Mauro Cimino, Elisabetta Bonfanti, Paolo Gelosa, Luigi Sironi, Maria P. Abbracchio, Leda Dimou

    In the adult brain NG2‐glia continuously generate mature, myelinating oligodendrocytes. To which extent the differentiation process is common to all NG2‐glia and whether distinct pools are recruited for repair under physiological and pathological conditions still needs clarification. Here, we aimed at investigating the differentiation potential of adult NG2‐glia that specifically express the G‐protein coupled receptor 17 (GPR17), a membrane receptor that regulates the differentiation of these cells at postnatal stages. To this aim, we generated the first BAC transgenic GPR17‐iCreERT2 mouse line for fate mapping studies. In these mice, under physiological conditions, GPR17+ cells —in contrast to GPR17‐ NG2‐glia— did not differentiate within 3 months, a peculiarity that was overcome after cerebral damage induced by acute injury or ischemia. After these insults, GPR17+ NG2‐glia rapidly reacted to the damage and underwent maturation, suggesting that they represent a ‘reserve pool’ of adult progenitors maintained for repair purposes. GLIA 2016;64:287–299


  • Oligodendroglial heterogeneity in time and space (NG2 glia in the CNS)

    by Leda Dimou, Michael Wegner

    NG2 glia represent a neural cell population that expresses the proteoglycan NG2 and is distinct from other cell types of the central nervous system. While they generate oligodendrocytes and a subset of astrocytes during development, their progeny in the adult brain solely consists of oligodendrocytes and further NG2 glia. In the last years, it has become clear that NG2 glia represent a heterogeneous population of cells with different properties and potential. In this review we will first discuss the similarities and differences between NG2 glia of the developing and adult CNS, before we will describe the regulatory mechanisms in these cells to finally concentrate on the heterogeneity of NG2 glia under physiological and pathological conditions.

  • Oligodendrogliale Heterogenität in Zeit und Raum (NG2 Glia im ZNS)

    by L. Dimou, Michael Wegner

    Zusammenfassung NG2 Glia stellen eine eigenständige neurale Zellpopulation dar, die über die Expression des Proteoglykans NG2 von anderen Zelltypen des zentralen Nervensystems unterschieden werden kann. Wahrend der Ontogenese generieren NG2 Glia Oligodendrozyten und eine Subpopulation von Astrozyten und im erwachsenen Gehirn bilden sie unter physiologischen Bedingungen ausschließlich Oligodendrozyten oder weitere NG2 Glia. Heute ist klar, dass NG2 Glia eine heterogene Population von Zellen mit unterschiedlichen Eigenschaften und Potenzial darstellen. In diesem Übersichtsartikel diskutieren wir zuerst die Gemeinsamkeiten und Unterschiede zwischen NG2 Glia im jungen und erwachsenen Gehirn und beschreiben dann molekulare Regulationsmechanismen in NG2 Glia, um anschließend auf die Heterogenität unter physiologischen und pathologischen Bedingungen einzugehen.

  • Oligodendroglial heterogeneity in time and space (NG2 glia in the CNS)

    by Leda Dimou, Michael Wegner

    NG2 glia represent a neural cell population that expresses the proteoglycan NG2 and is distinct from other cell types of the central nervous system. While they generate oligodendrocytes and a subset of astrocytes during development, their progeny in the adult brain solely consists of oligodendrocytes and further NG2 glia. In the last years, it has become clear that NG2 glia represent a heterogeneous population of cells with different properties and potential. In this review we will first discuss the similarities and differences between NG2 glia of the developing and adult CNS, before we will describe the regulatory mechanisms in these cells to finally concentrate on the heterogeneity of NG2 glia under physiological and pathological conditions.


  • NG2‐glia and their functions in the central nervous system

    by L. Dimou, V. Gallo

    In the central nervous system, NG2‐glia represent a neural cell population that is distinct from neurons, astrocytes, and oligodendrocytes. While in the past the main role ascribed to these cells was that of progenitors for oligodendrocytes, in the last years it has become more obvious that they have further functions in the brain. Here, we will discuss some of the most current and highly debated issues regarding NG2‐glia: Do these cells represent a heterogeneous population? Can they give rise to different progenies, and does this change under pathological conditions? How do they respond to injury or pathology? What is the role of neurotransmitter signaling between neurons and NG2‐glia? We will first give an overview on the developmental origin of NG2‐glia, and then discuss whether their distinct properties in different brain regions are the result of environmental influences, or due to intrinsic differences. We will then review and discuss their in vitro differentiation potential and in vivo lineage under physiological and pathological conditions, together with their electrophysiological properties in distinct brain regions and at different developmental stages. Finally, we will focus on their potential to be used as therapeutic targets in demyelinating and neurodegenerative diseases. Therefore, this review article will highlight the importance of NG2‐glia not only in the healthy, but also in the diseased brain. GLIA 2015;63:1429–1451


  • Shaping barrels: activity moves NG2+ glia

    by Leda Dimou, Magdalena Götz